Connect with us
Information
About Us
Contact Us
Careers
Partnerships
Advertise With Us
Authors
Browse Topics
Events
Disclaimer
Privacy Policy
Australia
North America
World
Login
Investing News
Network
Your trusted source for investing success
North America
Australia
World
My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
Reports & Guides
Market Outlook Reports
Investing Guides
Resource
Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals
Tech
Life Science
outlook therapeutics
POPULAR ARTICLES
Outlook Therapeutics Receives FDA Agreement for Special Protocol Assessments
Outlook Therapeutics Finishes Patient Enrollment for NOrse 1 Phase 3 Clinical Trial
Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
LATEST ARTICLES
Outlook Therapeutics Announces Reverse Stock Split
Pharmaceutical Investing
Outlook Therapeutics Closes Final Tranche of $20 Million Private Placement
Notes from the Floor: Biotech Showcase, Day 1
Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018
Oncobiologics Changes Name to Outlook Therapeutics
Latest News
Westport Announces Annual General and Special Meeting and Timing of Q1 2025 Financial Results
Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties
Canadian Investment Regulatory Organization Trade Resumption - FYL
Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties
Forte Minerals Engages Trion Communications GmbH for European Investor Awareness
More News
